HLS.AX - Healius Limited

ASX - ASX Delayed price. Currency in AUD

Healius Limited

Liberty Place
Level 22 161 Castlereagh Street
Sydney, NSW 2000
61 2 9432 9400

IndustryDiagnostics & Research
Full-time employees11,000

Key executives

NameTitlePayExercisedYear born
Ms. Maxine Jaquet B.Com.MD, CEO & Director1.44MN/AN/A
Mr. John McKechnieChief Exec. of the Pathology Division1.09MN/AN/A
Mr. Paul D. AndersonChief Financial OfficerN/AN/AN/A
Mr. Rob PhippsGroup Exec. of People & Culture and SustainabilityN/AN/AN/A
Dr. Phil LucasChief Exec. of Lumus ImagingN/AN/AN/A
Ian McphanChief Operating Officer of Healius PathologyN/AN/AN/A
Dr. Jan Van RooyenGroup Exec. of Healius PathologyN/AN/AN/A
Stephen HumphriesCompany Sec.N/AN/AN/A
Ms. Mary Ellen Weaver AGIACompany Sec.N/AN/AN/A
Dr. John HoustonAdvisorN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Corporate governance

Healius Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.